Revised forecast
Fiscal year ending January 2027 · Second quarter (interim period)Previous forecast published 19 March 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Due to the delayed reinstatement of EV subsidies in Europe and other factors, EV demand did not increase significantly, and shipment delays for ESS sales also occurred. As a result, revenue from the separator business decreased by ¥968 million versus plan. Revenue from the ion-exchange membrane business also decreased by ¥103 million versus plan, resulting in an overall revenue decrease of ¥1,071 million versus plan. Operating income was affected by lower production volumes and reduced machine utilization resulting from sluggish sales volumes, while the company advanced operational rationalization through cost reductions and improved margins in the ion-exchange membrane business.
| Item | Details |
|---|---|
| Net Sales | ¥3,000 million → ¥1,928 million（-35.7%） |
| Operating profit | ¥-1,200 million → ¥-1,388 million |
| Ordinary income | ¥-2,900 million → ¥-3,091 million |
| Profit attributable to owners of the parent | ¥-2,900 million → ¥-3,104 million |
| Net income per share | -52.55 yen and sen → -51.62 yen and sen |
| Fiscal Period Covered | Fiscal year ending January 2027 |
| Period Covered | Second quarter (interim period) |
| Publication date of previous forecast | 19 March 2026 |
| Previous-period results | Revenue ¥1,450 million, operating loss ¥2,868 million, ordinary loss ¥5,412 million, interim net loss attributable to owners of the parent ¥5,429 million, interim net loss per share ¥98.86 |
| Reason for the revision | Due to the delayed reinstatement of EV subsidies in Europe and other factors, EV demand did not increase significantly, and shipment delays for ESS sales also occurred. As a result, revenue from the separator business decreased by ¥968 million versus plan. Revenue from the ion-exchange membrane business also decreased by ¥103 million versus plan, resulting in an overall revenue decrease of ¥1,071 million versus plan. Operating income was affected by lower production volumes and reduced machine utilization resulting from sluggish sales volumes, while the company advanced operational rationalization through cost reductions and improved margins in the ion-exchange membrane business. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The reinstatement of EV subsidies in Europe was delayed, and EV demand has not increased significantly. In addition, shipment delays for ESS sales caused revenue from the separator business to fall below plan. Lower production volumes and reduced machine utilization resulting from sluggish sales volumes put downward pressure on operating income, while the company advanced operational rationalization through cost reductions and improved margins in the ion-exchange membrane business.